Medicare Part D coverage · calcium acetate · RxCUI 197433
calcium acetate 667 MG Oral Tablet
Per the CMS 2026 Part D formulary file, calcium acetate 667 MG Oral Tablet is covered by 1,693 Medicare Part D plans (33.5% of enrollable products), averaging Tier 2.2, with prior authorization required on 26.8% of covering formularies.
- 33.5%
- Plan coverage
- 1,693
- Plans covering
- T2.2
- Avg tier
- 26.8%
- Prior auth required
What the CMS Formulary Data Shows for calcium acetate 667 MG Oral Tablet
Per the CMS 2026 Part D formulary file, calcium acetate 667 MG Oral Tablet (RxNorm concept RXCUI 197433, generic name calcium acetate) appears on 138 distinct formulary files spanning 1,693 Medicare Part D plan offerings - 33.5% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 2.2.
Real-world access to calcium acetate 667 MG Oral Tablet depends on utilization management as much as tier placement: 26.8% of covering formularies require prior authorization. 0% require step therapy. 10.1% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 108,459 Part D beneficiaries filled calcium acetate 667 MG Oral Tablet in 2023, with total plan-and-beneficiary spending of $35,764,380 and an average per-beneficiary annual cost of $329.75. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry calcium acetate 667 MG Oral Tablet today.
Coverage Details
- Formularies covering
- 138
- Plans covering
- 1,693
- Coverage rate
- 33.5%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 2, Generic
Restrictions
- Prior authorization required
- 26.8% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 10.1% of formularies
2023 Medicare Spending
- Beneficiaries
- 108,459
- Total spending
- $35,764,380
- Avg per beneficiary
- $329.75
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering calcium acetate 667 MG Oral Tablet
100 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| ElderServe MAP (HMO D-SNP) | Elderserve Health, Inc. | T1 | Yes | $0 | NY |
| Cooperative Advantage (HMO D-SNP) | Group Health Cooperative OF EAU Claire | T1 | Yes | $0 | WI |
| Longevity Health Plan (PPO I-SNP) | Longevity Health Plan OF NEW Jersey Insurance Comp | T1 | Yes | $0 | NJ |
| Upper Peninsula Health Plan MI Coordinated Health (HMO D-SNP) | Upper Peninsula Health Plan, LLC | T1 | Yes | $0 | MI |
| CareSource Dual Advantage (HMO D-SNP) | Caresource Georgia Co. | T1 | Yes | $0 | GA |
| HAP CareSource MI Coordinated Health (HMO D-SNP) | HAP Caresource | T1 | Yes | $0 | MI |
| NaviCare (HMO D-SNP) | Fallon Community Health Plan | T1 | No | $0 | MA |
| PHP (HMO C-snp) | Aids Healthcare Foundation | T1 | No | $0 | CA |
| Elevate Medicare Choice (HMO D-SNP) | Denver Health Medical Plan, Inc. | T1 | No | $0 | CO |
| AllCare Advantage Redwood Rx (HMO D-SNP) | Allcare Health Plan, Inc. | T1 | No | $0 | OR |
| PrimeWest Senior Health Complete (HMO D-SNP) | Primewest Rural MN Health Care Access Initiative | T1 | No | $0 | MN |
| Prime Health Complete (HMO D-SNP) | Primewest Rural MN Health Care Access Initiative | T1 | No | $0 | MN |
| DualConnect (HMO D-SNP) | Santa Clara County Health Authority | T1 | No | $0 | CA |
| VNS Health Total (HMO D-SNP) | VNS Choice | T1 | No | $0 | NY |
| Alterwood Advantage Dual Secure (HMO D-SNP) | Alterwood Advantage, Inc. | T1 | No | $0 | MD |
| Generations Classic Rewards (HMO) | Globalhealth, Inc. | T1 | No | $0 | OK |
| Generations Classic Plus (HMO) | Globalhealth, Inc. | T1 | No | $0 | OK |
| Generations Chronic Care (HMO C-SNP) | Globalhealth, Inc. | T1 | No | $0 | OK |
| Generations Chronic Care Savings (HMO C-SNP) | Globalhealth, Inc. | T1 | No | $0 | OK |
| Generations Dual Support (HMO D-SNP) | Globalhealth, Inc. | T1 | No | $0 | OK |
Show the next 30 plans
| Generations Dual Premier (HMO D-SNP) | Globalhealth, Inc. | T1 | No | $0 | OK |
| Nascentia Dual Advantage (HMO D-SNP) | Visiting Nurse Association OF Central NEW York | T1 | No | $0 | NY |
| Provider Partners Pennsylvania Community Plan (HMO I-SNP) | Provider Partners Health Plan OF Pennsylvania, Inc | T1 | No | $0 | PA |
| Provider Partners North Carolina Community Plan (HMO I-SNP) | Provider Partners Health Plan OF North Carolina | T1 | No | $0 | NC |
| Provider Partners Indiana Community Plan (HMO I-SNP) | Provider Partners Health Plan OF Indiana | T1 | No | $0 | IN |
| Provider Partners Missouri Community Plan (HMO I-SNP) | Provider Partners Health Plan OF Missouri, Inc. | T1 | No | $0 | MO |
| Abilis Health Community (HMO I-SNP) | Signature Advantage, LLC | T1 | No | $0 | KY, TN |
| Arkansas Integrated Providers (AIP) Dual Advantage (HMO D-SNP) | Arkansas Superior Select, Inc. | T1 | No | $0 | AR |
| Mass General Brigham SCO (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | No | $0 | MA |
| Mass General Brigham One Care (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | No | $0 | MA |
| Tufts Health One Care (HMO D-SNP) | Tufts Health Public Plans, Inc. | T1 | No | $0 | MA |
| Tufts Health One Care CW (HMO D-SNP) | Tufts Health Public Plans, Inc. | T1 | No | $0 | MA |
| Tufts Health Plan Senior Care Options (HMO D-SNP) | Tufts Associated Health Maintenance Organization | T1 | No | $0 | MA |
| Tufts Health Plan Senior Care Options CW (HMO D-SNP) | Tufts Associated Health Maintenance Organization | T1 | No | $0 | MA |
| Leon MediExtra (HMO) | Leon Health, Inc. | T1 | No | $0 | FL |
| Leon MediDual (HMO D-SNP) | Leon Health, Inc. | T1 | No | $0 | FL |
| Leon MediMore (HMO) | Leon Health, Inc. | T1 | No | $0 | FL |
| Leon MediMax (HMO D-SNP) | Leon Health, Inc. | T1 | No | $0 | FL |
| Longevity Health Plan (HMO I-SNP) | Longevity Health Plan OF Florida, Inc. | T1 | Yes | $4.80 | FL |
| Gold Dialysis & Kidney Complete (HMO-POS C-SNP) | Gold Kidney OF Florida Inc | T1 | No | $4.80 | FL |
| Provider Partners Texas Advantage Plan (HMO I-SNP) | Provider Partners Health Plan OF Texas, Inc. | T1 | No | $4.80 | TX |
| Texas Independence Health Plan, Inc. (HMO I-SNP) | Texas Independence Health Plan, Inc. | T1 | No | $4.80 | TX |
| Texas Independence Community Plan (HMO I-SNP) | Texas Independence Health Plan, Inc. | T1 | No | $4.80 | TX |
| Longevity Health Plan (HMO I-SNP) | Longevity Health Plan OF Michigan, Inc. | T1 | Yes | $8.80 | MI |
| Tribute Select (HMO-POS I-SNP) | Arkansas Superior Select, Inc. | T1 | No | $8.90 | AR |
| ATRIO Special Needs Plan (HMO D-SNP) | Atrio Health Plans | T1 | No | $10.50 | OR |
| ATRIO Special Needs Plan (HMO D-SNP) | Atrio Health Plans | T1 | No | $10.50 | OR |
| Longevity Health Plan (HMO I-SNP) | Longevity Health Plan OF Illinois, Inc. | T1 | Yes | $15.20 | IL |
| Provider Partners Illinois Advantage Plan (HMO I-SNP) | Provider Partners Health Plan OF Illinois | T1 | No | $15.20 | IL |
| Gold Dialysis & Kidney Complete (HMO-POS C-SNP) | Gold Kidney OF Arizona | T1 | No | $17.00 | AZ |
Showing top 50 of 100 plans.
Frequently Asked Questions
Is calcium acetate 667 MG Oral Tablet covered by Medicare Part D?
Yes, calcium acetate 667 MG Oral Tablet is covered by 1,693 Medicare Part D plans (33.5% of all Part D formularies).
What tier is calcium acetate 667 MG Oral Tablet on Medicare Part D plans?
calcium acetate 667 MG Oral Tablet averages Tier 2.2 across Part D plans, ranging from Tier 1 to Tier 4.
Does calcium acetate 667 MG Oral Tablet require prior authorization?
26.8% of Part D formularies require prior authorization for calcium acetate 667 MG Oral Tablet. Step therapy: 0%. Quantity limits: 10.1%.
How much does Medicare spend on calcium acetate 667 MG Oral Tablet?
In 2023, total Medicare Part D spending on calcium acetate 667 MG Oral Tablet was $35,764,380, covering 108,459 beneficiaries. The average spend per beneficiary was $329.75.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- 0.5 ML Haemophilus influenzae type b strain 20752, capsular polysaccharide inactivated tetanus toxoid conjugate vaccine 0.07 MG/ML Injection [Hiberix] T2.2
- promethazine hydrochloride 12.5 MG Oral Tablet T2.2
- misoprostol 0.1 MG Oral Tablet T2.2
- promethazine hydrochloride 25 MG Oral Tablet T2.2
- promethazine hydrochloride 50 MG Oral Tablet T2.2
- amphetamine aspartate 3.125 MG / amphetamine sulfate 3.125 MG / dextroamphetamine saccharate 3.125 MG / dextroamphetamine sulfate 3.125 MG Oral Tablet T2.2
Similar prior-authorization rate
- calcipotriene 0.05 MG/ML Topical Solution 26.8% PA
- lorazepam 2 MG/ML Oral Solution 26.8% PA
- alprazolam 1 MG/ML Oral Solution 26.9% PA
- phenoxybenzamine hydrochloride 10 MG Oral Capsule 26.7% PA
- 24 HR paroxetine hydrochloride 37.5 MG Extended Release Oral Tablet 26.7% PA
- 24 HR paroxetine hydrochloride 12.5 MG Extended Release Oral Tablet 26.6% PA